Observational Model: Case-Only, Time Perspective: Prospective
Occurrence of SAEs, adverse events (AEs) considered to be related to ESMYA or AEs leading to ESMYA treatment discontinuation.
Patients will be followed from baseline up to 15 months
Jaime Oliver, MD
Germany: Ethics Commission